These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3058446)

  • 21. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
    Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
    Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pressor and adrenal responses to angiotensin II in patients with normoreninemic essential hypertension--the influence of sodium intake and captopril].
    Kuroda K; Ito K; Sakaguchi A; Kimura G; Uda M; Kojima S; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):179-88. PubMed ID: 6353007
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of plasma renin-angiotensin system to a single captopril administration in patients receiving long-term treatment with captopril.
    Iwata T; Dazai Y; Kitami Y; Muneta S; Imamura Y; Murakami E; Hiwada K
    Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):705-9. PubMed ID: 1424299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects].
    Seto S; Kaku T; Shinagawa T; Matsumoto Y; Doi Y; Tasaki S; Murayama M; Aoi W; Kuramochi M; Hashiba K
    Nihon Naika Gakkai Zasshi; 1980 Nov; 69(11):1439-46. PubMed ID: 7017040
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Responses of renin-angiotensin-aldosterone system to insulin hypoglycemia in patients with essential hypertension (author's transl)].
    Ishimaru K; Saito H; Oshima I; Saito S; Susaki S; Matsuda M; Mori H
    Nihon Jinzo Gakkai Shi; 1978 Oct; 20(10):1087-93. PubMed ID: 732035
    [No Abstract]   [Full Text] [Related]  

  • 30. [The renin-angiotensin-aldosterone system in essential arterial hypertension].
    Ruilope L; Alcazar JM; García Robles R; Gutiérrez Millet V; Jarillo MD; Torres J; Morales JM; Rodicio JL
    Rev Clin Esp; 1977 Sep; 146(5):233-7. PubMed ID: 928859
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
    [No Abstract]   [Full Text] [Related]  

  • 32. [Essential hypertension and the renin-angiotensin-aldosterone system].
    Kokot F
    Kardiol Pol; 1975; 18(3):209-18. PubMed ID: 1142580
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):353-61. PubMed ID: 2991636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypotensive effects of angiotensin I converting enzyme inhibitor, and relationship between kallikrein-kinin system and renin-angiotensin-aldosterone system].
    Mizuno K; Gotoh M; Haruyama K; Ikeda K; Hashimoto S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1983 Jan; 25(1):59-66. PubMed ID: 6341658
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J; Lijnen P; Fagard R; Verschueren LJ; Amery A
    J Endocrinol; 1981 Dec; 91(3):457-65. PubMed ID: 7035596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of atriopeptin on the plasma renin-angiotensin system in rats].
    Ding JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Aug; 14(4):233-4, 254. PubMed ID: 2949951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.